Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Hidden prediabetes common in dialysis patients, study finds

NCT ID NCT07337083

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at how common prediabetes is in people with end-stage kidney disease who are on dialysis. Researchers screened 262 adult dialysis patients who had never been diagnosed with diabetes or prediabetes. The goal was to find out how many had prediabetes, which can increase the risk of developing diabetes later on.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

262 people

The number who actually took part.

Started

Apr 2025

Finished

Oct 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population is defined as adult patients (aged 18 years or older) with End-Stage Renal Disease (ESRD) who are currently on dialysis. This population will be recruited from a single center: Sohag Faculty of Medicine, Sohag University, Egypt.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * End stage renal disease on dialysis patients aged ≥ 18 years old. Exclusion Criteria: 1. Patients previously diagnosed with prediabetes. 2. Patients previously diagnosed with diabetes mellitus. 3. Acute Medical Status :Hospitalized patients. 4. Physiological States: Pregnant females.Lactating females. 5. Specific Comorbidities \& Conditions: Polycystic kidney disease. 6. New York Heart Association (NYHA) class III or IV heart failure. 7. Known liver cirrhosis. or HIV/AIDS. 8. Renal cancer. 9. Active immunosuppression. or Recent chemotherapy or immunosuppressive therapy. 10. History of organ transplantation.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic renal failure (CRF) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Faculty of Medicine

    Sohag, Egypt, 82525, Egypt

  • Sohag University .Faculty of Medicine

    Sohag, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.